Correlation Between Immix Biopharma and Enveric Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and Enveric Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and Enveric Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immix Biopharma and Enveric Biosciences, you can compare the effects of market volatilities on Immix Biopharma and Enveric Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of Enveric Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and Enveric Biosciences.

Diversification Opportunities for Immix Biopharma and Enveric Biosciences

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Immix and Enveric is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and Enveric Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enveric Biosciences and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with Enveric Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enveric Biosciences has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and Enveric Biosciences go up and down completely randomly.

Pair Corralation between Immix Biopharma and Enveric Biosciences

Given the investment horizon of 90 days Immix Biopharma is expected to under-perform the Enveric Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Immix Biopharma is 1.98 times less risky than Enveric Biosciences. The stock trades about -0.07 of its potential returns per unit of risk. The Enveric Biosciences is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  31.00  in Enveric Biosciences on October 22, 2024 and sell it today you would earn a total of  4.00  from holding Enveric Biosciences or generate 12.9% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Immix Biopharma  vs.  Enveric Biosciences

 Performance 
       Timeline  
Immix Biopharma 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Immix Biopharma are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, Immix Biopharma showed solid returns over the last few months and may actually be approaching a breakup point.
Enveric Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enveric Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Immix Biopharma and Enveric Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Immix Biopharma and Enveric Biosciences

The main advantage of trading using opposite Immix Biopharma and Enveric Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, Enveric Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enveric Biosciences will offset losses from the drop in Enveric Biosciences' long position.
The idea behind Immix Biopharma and Enveric Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation